Form 8-K - Current report:
SEC Accession No. 0001437749-25-019177
Filing Date
2025-06-02
Accepted
2025-06-02 16:50:35
Documents
20
Period of Report
2025-05-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20250602_8k.htm   iXBRL 8-K 31206
2 EXHIBIT 3.1 ex_825844.htm EX-3.1 168440
3 EXHIBIT 3.2 ex_826039.htm EX-3.2 179677
4 EXHIBIT 99.1 ex_825845.htm EX-99.1 15464
9 d02.jpg GRAPHIC 1514
10 d03.jpg GRAPHIC 1490
11 dyadiclogo.jpg GRAPHIC 4172
12 logosm2.jpg GRAPHIC 3563
  Complete submission text file 0001437749-25-019177.txt   627669

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dyai-20250529.xsd EX-101.SCH 3578
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20250529_def.xml EX-101.DEF 12186
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20250529_lab.xml EX-101.LAB 16395
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20250529_pre.xml EX-101.PRE 12456
22 EXTRACTED XBRL INSTANCE DOCUMENT dyai20250602_8k_htm.xml XML 3064
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 251015780
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)